A Nomogram Based on Comorbidities and Infection Location to Predict 30 Days Mortality of Immunocompromised Patients in ICU: A Retrospective Cohort Study
Open Access
- 1 December 2021
- journal article
- research article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 14, 10281-10292
Abstract
Background: The existing comorbidity indexes, like Charlson Comorbidity Index (CCI) and the Elixhauser Comorbidity Index (ECI), do not take infection factors into account for critically ill patients with immunocompromise, bringing about a decrease of prediction accuracy. Therefore, we attempted to incorporate infection location into the analysis to construct a rapid comorbidity scoring system independent of laboratory tests. Methods: Data were extracted from the Multiparameter Intelligent Monitoring in Intensive Care III database. A total of 3904 critically ill patients with immunocompromise admitted to ICU were enrolled and assigned into training or validation sets according to the date of ICU admission. The predictive nomogram was constructed in the training set based on logistic regression analysis and then undergone validation in the validation set in comparison with SOFA, CCI and ECI. Results: Factors eligible for the nomogram included patient’s age, gender, ethnicity, underlying disease of immunocompromise like metastatic cancer and leukemia, possible infection on admission including pulmonary infection, urinary tract infection and blood infection, and one comorbidity, coagulopathy. The nomogram we developed exhibited better discrimination than SOFA, CCI and ECI with an area under the receiver operating characteristic curve (AUC) of 0.739 (95% CI 0.707– 0.771) and 0.746 (95% CI 0.713– 0.779) in the training and validation sets, respectively. Combining the nomogram and SOFA could bring a new prediction model with a superior predictive effect in both sets (training set AUC = 0.803 95% CI 0.777– 0.828, validation set AUC = 0.818 95% CI 0.783– 0.854). The calibration curve exhibited coherence between the nomogram and ideal observation for two cohorts (p> 0.05). Decision curve analysis revealed the clinical usefulness of the nomogram in both sets. Conclusion: We established a nomogram that could provide an accurate assessment of 30 days ICU mortality in critically ill patients with immunocompromise, which can be employed to evaluate the short-term prognosis of those patients and bring more clinical benefits without dependence on laboratory tests.Keywords
This publication has 55 references indexed in Scilit:
- The Application of Comorbidity Indices to Predict Early Postoperative Outcomes After Laparoscopic Roux-en-Y Gastric Bypass: A Nationwide Comparative Analysis of Over 70,000 CasesObesity Surgery, 2013
- Systematic Review of Comorbidity Indices for Administrative DataMedical Care, 2012
- Association of gender with outcomes in critically ill patientsCritical Care, 2012
- A comparison of charlson and elixhauser comorbidity measures to predict colorectal cancer survival using administrative health dataCancer, 2010
- Candidiasis in pediatric patients with cancer interned in a university hospitalBrazilian Journal of Microbiology, 2009
- Acute Congestive Heart Failure in the Emergency DepartmentCardiology Clinics, 2006
- Gender-related differences in intensive care: A multiple-center cohort study of therapeutic interventions and outcome in critically ill patients*Critical Care Medicine, 2003
- The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring GroupJAMA, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Pulmonary Disease in the Immunocompromised Host (First of Two Parts)Mayo Clinic Proceedings, 1985